Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Feebris’ AI-guided virtual care platform has demonstrated significant impact in improving access to healthcare for vulnerable populations. Studies show increased treatment within the community (from 4% to 76%), reduced hospital consultations (from 34% to 7%), and decreased loss of daily wages among patients. The technology has been deployed across over one hundred sites in the UK and internationally for both paediatric and elderly care settings. Real-world evaluations report at least a 20% reduction in hospital admissions from care homes using the system. The solution was also recognized during COVID‑19 for supporting remote diagnosis while reducing unnecessary hospitalizations. Published research supports its effectiveness at scale.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Feebris.